Health Technology Assessment

Health Technology Assessment (HTA) can be performed alongside the total translational research process. After phase III trials, HTA (e.g. a cost-effectiveness analysis) is used to apply for reimbursement. In earlier stages of the translational research process, “early HTA” can be used to anticipate on technological and environmental developments.

The vision of HTA in the NKI is to improve early detection, care and access (in terms of coverage and actual availability) of patients to cancer health services.
Our mission is to create evidence, using comprehensive assessments and innovative modeling techniques for informed decision making regarding new and existing (complex) technologies in oncology.